Therapeutic Programs

therapeutic programs

Pipeline

ProgramStatus of Development

Androgen Receptor

Castration-Resistant Prostate Cancer (Oral)

ExploratoryLead OptimizationIND-EnablingPhase 1/2

Estrogen Receptor

Breast Cancer (Oral)

ExploratoryLead OptimizationIND-EnablingPhase 1/2

Arvinas Target #1

(Undisclosed)

ExploratoryLead OptimizationIND-EnablingPhase 1/2

Arvinas Target #2

(Undisclosed)

ExploratoryLead OptimizationIND-EnablingPhase 1/2